Andrew W Hahn

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Metastatic Renal Cell Carcinoma

Tyrosine Kinase

Radical Prostatectomy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Prostate cancer and prostatic diseases

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Ana M Aparicio, Rebecca S Slack Tidwell, Shalini Singh Yadav, Jiun-Sheng Chen, Miao Zhang, JIngjing Liu, Shuai Guo, Patrick G Pilié, Yao Yu, Xingzhi Song, Haswanth Vundavilli, Sonali Jindal, Keyi Zhu, Paul V Viscuse, Justin M Lebenthal, Andrew W Hahn, Rama Soundararajan, Paul Gettys Corn, Amado J Zurita, Sumit K Subudhi, Jianhua Zhang, Wenyi Wang, Chad D Huff, Patricia Troncoso, James P Allison, Padmanee Sharma, Christopher L Logothetis
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana M Aparicio, Rebecca S Slack Tidwell, Shalini Singh Yadav, Jiun-Sheng Chen, Miao Zhang, JIngjing Liu, Shuai Guo, Patrick G Pilié, Yao Yu, Xingzhi Song, Haswanth Vundavilli, Sonali Jindal, Keyi Zhu, Paul V Viscuse, Justin M Lebenthal, Andrew W Hahn, Rama Soundararajan, Paul Gettys Corn, Amado J Zurita, Sumit K Subudhi, Jianhua Zhang, Wenyi Wang, Chad D Huff, Patricia Troncoso, James P Allison, Padmanee Sharma, Christopher L Logothetis
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana M Aparicio, Rebecca S Slack Tidwell, Shalini Singh Yadav, Jiun-Sheng Chen, Miao Zhang, JIngjing Liu, Shuai Guo, Patrick G Pilié, Yao Yu, Xingzhi Song, Haswanth Vundavilli, Sonali Jindal, Keyi Zhu, Paul V Viscuse, Justin M Lebenthal, Andrew W Hahn, Rama Soundararajan, Paul Gettys Corn, Amado J Zurita, Sumit K Subudhi, Jianhua Zhang, Wenyi Wang, Chad D Huff, Patricia Troncoso, James P Allison, Padmanee Sharma, Christopher L Logothetis
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana M Aparicio, Rebecca S Slack Tidwell, Shalini Singh Yadav, Jiun-Sheng Chen, Miao Zhang, JIngjing Liu, Shuai Guo, Patrick G Pilié, Yao Yu, Xingzhi Song, Haswanth Vundavilli, Sonali Jindal, Keyi Zhu, Paul V Viscuse, Justin M Lebenthal, Andrew W Hahn, Rama Soundararajan, Paul Gettys Corn, Amado J Zurita, Sumit K Subudhi, Jianhua Zhang, Wenyi Wang, Chad D Huff, Patricia Troncoso, James P Allison, Padmanee Sharma, Christopher L Logothetis
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Andrew W Hahn, Rebecca S Slack Tidwell, Patrick G Pilie, Yao Yu, Jingjing Liu, Devaki Shilpa Surasi, Mark Titus, Jianhua Zhang, Neha Venkatesh, Theocharis Panaretakis, Justin R Gregg, Amado J Zurita, Bilal A Siddiqui, Paul G Corn, Sumit K Subudhi, Pavlos Msaouel, Efstratios Koutroumpakis, Chad D Huff, Ana M Aparicio, Jennifer L McQuade, Daniel E Frigo, Christopher L Logothetis
Body composition as a determinant of the therapeutic index with androgen signaling inhibition. Prostate cancer and prostatic diseases (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Andrew W Hahn, Efstratios Koutroumpakis, Vivek Narayan, Ana M Aparicio
The need for precision medicine in managing cardiovascular risk for men receiving ADT. Prostate cancer and prostatic diseases (2024)
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, Miao Zhang, Yao Yu, Curtis A Pettaway, Lisly Chery, Louis L Pisters, John F Ward, Justin R Gregg, John Papadopoulos, Ashish M Kamat, Marisa Lozano, Anh Hoang, Bradley Broom, Xuemei Wang, Chad D Huff, Christopher J Logothetis, Patricia Troncoso, Patrick G Pilié, John W Davis
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU international (2024)
Ana M Aparicio, Rebecca S Slack Tidwell, Shalini Singh Yadav, Jiun-Sheng Chen, Miao Zhang, JIngjing Liu, Shuai Guo, Patrick G Pilié, Yao Yu, Xingzhi Song, Haswanth Vundavilli, Sonali Jindal, Keyi Zhu, Paul V Viscuse, Justin M Lebenthal, Andrew W Hahn, Rama Soundararajan, Paul Gettys Corn, Amado J Zurita, Sumit K Subudhi, Jianhua Zhang, Wenyi Wang, Chad D Huff, Patricia Troncoso, James P Allison, Padmanee Sharma, Christopher L Logothetis
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Wassim Abida, Andrew W Hahn, Neal D Shore, Archana M Agarwal, Paul R Sieber, Matthew R Smith, Tanya Barauskas Dorff, J Paul Monk, Matthew B Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Christopher L Logothetis, Michael J Morris
Phase 1 Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Progressing on Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, Miao Zhang, Yao Yu, Curtis A Pettaway, Lisly Chery, Louis L Pisters, John F Ward, Justin R Gregg, John Papadopoulos, Ashish M Kamat, Marisa Lozano, Anh Hoang, Bradley Broom, Xuemei Wang, Chad D Huff, Christopher J Logothetis, Patricia Troncoso, Patrick G Pilié, John W Davis
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU international 134 (3) (2024)
Andrew W Hahn, Bilal A Siddiqui, Javier Leo, Eleonora Dondossola, Kaitlin J Basham, Cindy K Miranti, Daniel E Frigo
Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer. Endocrinology (2023)
Emanuela Gentile, Andrew W Hahn, Jian H Song, Anh Hoang, Peter D A Shepherd, Ramachandran Sumankalai, Nora M Navone, Eleni Efstathiou, Mark Titus, Paul Gettys Corn, Sue-Hwa Lin, Christopher L Logothetis, Theocharis Panaretakis
Monitoring Glucocorticoid Receptor in plasma derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer. Cancer research communications (2023)
Andrew W Hahn, Neha Venkatesh, Pavlos Msaouel, Jennifer L McQuade
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms. Cells 12 (21) (2023)
Omar Alhalabi, Roman Groisberg, Ralph Zinner, Andrew W Hahn, Aung Naing, Shizhen Zhang, Apostolia-Maria Tsimberidou, Jordi Rodon, Siqing Fu, Timothy Anthony Yap, David S Hong, Ming Sun, Yunfang Jiang, Shubham Pant, Amishi Y Shah, Amado J Zurita, Nizar M Tannir, Raghunandan Vikram, Jason Roszik, Funda Meric-Bernstam, Vivek Subbiah
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies. NPJ precision oncology 7 (1) (2023)
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele, Matthew T Campbell, Amado J Zurita, Amishi Y Shah, Eric Jonasch, Jianjun Gao, Sangeeta Goswami, Omar Alhalabi, Priya Rao, Kanishka Sircar, Nizar M Tannir, Pavlos Msaouel
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The oncologist (2023)
Umang Swami, Nicolas Sayegh, Yeonjung Jo, Benjamin Haaland, Taylor Ryan McFarland, Roberto H Nussenzveig, Divyam Goel, Deepika Sirohi, Andrew W Hahn, Benjamin L Maughan, Amir Goldkorn, Archana M Agarwal
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer. Molecular cancer therapeutics 21 (12) (2022)
Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira, Ryan C Augustin, Mingchu Xu, Jun Li, Xiaogang Wu, Aditya K Mishra, Tuba Nur Gide, Camelia Quek, Yan Zang, Christine N Spencer, Alexander M Menzies, Carrie R Daniel-MacDougall, Courtney W Hudgens, Theodore Scott Nowicki, Lauren E Haydu, Md Abdul Wadud Khan, Vancheswaran Gopalakrishnan, Elizabeth M Burton, Jared C Malke, Julie M Simon, Chantale Bernatchez, Nagireddy Putluri, Scott E Woodman, Vashisht Gopal Y N, Renato A Guerrieri, Grant M Fischer, Jian Wang, Khalida M Wani, John F Thompson, Jeffrey E Lee, Patrick Hwu, Nadim J Ajami, Jeffrey E Gershenwald, Georgina V Long, Richard A Scolyer, Michael T Tetzlaff, Alexander J F Lazar, Dirk Schadendorf, Jennifer A Wargo, Joanne M Jeter, Ralph J DeBerardinis, Han Liang, P Andrew Futreal, Jianhua Zhang, James S Wilmott, Weiyi Peng, Michael A Davies, Greg M Delgoffe, Yana G Najjar, Jennifer Leigh McQuade
Obesity is associated with altered tumor metabolism in metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Andrew W Hahn, Nazli Dizman, Pavlos Msaouel
Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive. Therapeutic advances in medical oncology 14 (2022)
Minas J Sakellakis, Andrew W Hahn, Sumankalai Ramachandran, Miao Zhang, Anh Hoang, Jian H Song, Jingjing Liu, Feng Wang, Hirak S Basu, Peter Sheperd, Xuemei Wang, Daniel E Frigo, Sue-Hwa Lin, Theocharis Panaretakis, Jianhua Zhang, Nora M Navone, Patricia Troncoso, Christopher L Logothetis, Mark A Titus
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate cancer and prostatic diseases (2022)
Andrew W Hahn, Daniel J George, Archana M Agarwal
An Evolving Role for AXL in Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Andrew W Hahn, Jad Chahoud, Matthew T Campbell, Daniel D Karp, Jennifer Wang, Bettzy Stephen, Shi-Ming Tu, Curtis A Pettaway, Aung Naing
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial. Investigational new drugs 39 (5) (2021)
Andrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, Lianchun Xiao, Munevver Duran, Jeremy A Ross, Eric Jonasch, Amishi Yogesh Shah, Matthew T Campbell, Pavlos Msaouel, Nizar M Tannir
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies. The oncologist 26 (6) (2021)
Archana M Agarwal, Roberto H Nussenzveig, Andrew W Hahn, John M Hoffman, Kathryn Morton, Sumati Gupta, Julia Batten, Jared Thorley, Josiah Hawks, Victor Sacristan Santos, Gayatri Nachaegari, Xuechen Wang, Kenneth M Boucher, Benjamin Haaland, Benjamin L Maughan
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2020)
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, Alexander Y Andreev-Drakhlin, Funda Meric-Bernstam, Aung Naing, Sarina Piha-Paul, Filip Janku, Shubham Pant, Timothy Anthony Yap, David S Hong, Siqing Fu, Daniel Karp, Matthew T Campbell, Hung Le, Amishi Y Shah, Nizar M Tannir, Arlene O Siefker-Radtke, Jianjun Gao, Jason Roszik, Vivek Subbiah
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes. Molecular cancer research : MCR 19 (3) (2020)
Andrew W Hahn, Sumanta K Pal, Archana M Agarwal
Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma. The oncologist (2019)
Guru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, Rebecca J Nagy, Roberto H Nussenzveig, Andrew W Hahn, Oliver Sartor, Theodore Stewart Gourdin, Lakshminarayanan Nandagopal, Elisa M Ledet, Gurudatta Naik, Andrew J Armstrong, Jue Wang, Mehmet Asim Bilen, Shilpa Gupta, Petros Grivas, Sumanta Kumar Pal, Richard B Lanman, AmirAli Talasaz, Michael B Lilly
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer 125 (9) (2019)
Andrew W Hahn, Sumanta K Pal, Archana M Agarwal
Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma. The oncologist 25 (3) (2019)
Andrew W Hahn, David M Gill, Austin Poole, Roberto H Nussenzveig, Sara Wilson, James M Farnham, Robert A Stephenson, Lisa A Cannon-Albright, Benjamin L Maughan, Neeraj Agarwal
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC). Molecular cancer therapeutics 18 (3) (2018)
Neeraj Agarwal, Sumanta K Pal, Andrew W Hahn, Roberto H Nussenzveig, Gregory R Pond, Sumati V Gupta, Jue Wang, Mehmet A Bilen, Gurudatta Naik, Pooja Ghatalia, Christopher J Hoimes, Dharmesh Gopalakrishnan, Pedro C Barata, Alexandra Drakaki, Bishoy M Faltas, Lesli A Kiedrowski, Richard B Lanman, Rebecca J Nagy, Nicholas J Vogelzang, Kenneth M Boucher, Ulka N Vaishampayan, Guru Sonpavde, Petros Grivas
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA. Cancer 124 (10) (2018)